POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia

Nature Genetics

Volumn 45, Issue 5, 2013, Pages 526-530

  Ramsay, Andrew J ^a   Quesada, Víctor ^a   Foronda, Miguel ^b   Conde, Laura ^c   Martínez Trillos, Alejandra ^c   Villamor, Neus ^c   Rodríguez, David ^a   Kwarciak, Agnieszka ^a   Garabaya, Cecilia ^a   Gallardo, Mercedes ^b   López Guerra, Mónica ^c   López Guillermo, Armando ^c   Puente, Xose S ^a   Blasco, María A ^b   Campo, Elías ^c   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; OLIGOSACCHARIDE; PROTECTION OF TELOMERES 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHRONIC LYMPHATIC LEUKEMIA; DNA BINDING; EXOME; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; HUMAN; PRIORITY JOURNAL; SOMATIC MUTATION; TELOMERE;

AMINO ACID SEQUENCE; CHROMOSOME ABERRATIONS; EXOME; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDES; OLIGOSACCHARIDES; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; TELOMERE; TELOMERE-BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 84878551940     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2584     Document Type: Article

References (33)

1. Rozman, C. & Montserrat, E. Chronic lymphocytic leukemia. N. Engl. J. Med. 333, 1052-1057 (1995).
2. Zenz, T., Mertens, D., Kuppers, R., Dohner, H. & Stilgenbauer, S. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat. Rev. Cancer 10, 37-50 (2010).
3. Pekarsky, Y., Zanesi, N. & Croce, C.M. Molecular basis of CLL. Semin. Cancer Biol. 20, 370-376 (2010).
4. Cramer, P. & Hallek, M. Hematological cancer in 2011: new therapeutic targets and treatment strategies. Nat. Rev. Clin. Oncol. 9, 72-74 (2012).
5. Puente, X.S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101-105 (2011).
6. Quesada, V. et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet. 44, 47-52 (2012).
7. Fabbri, G. et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J. Exp. Med. 208, 1389-1401 (2011).
8. Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365, 2497-2506 (2011).
9. Baumann, P. & Cech, T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292, 1171-1175 (2001).
10. Loayza, D. & De Lange, T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013-1018 (2003).
11. González-Pérez, A. & Lopez-Bigas, N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am. J. Hum. Genet. 88, 440-449 (2011).
12. Tejera, A.M. et al. TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice. Dev. Cell 18, 775-789 (2010).
13. Martínez, P. et al. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev. 23, 2060-2075 (2009).
14. Sfeir, A., Kabir, S., van Overbeek, M., Celli, G.B. & de Lange, T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 327, 1657-1661 (2010).
15. Lei, M., Podell, E.R. & Cech, T.R. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat. Struct. Mol. Biol. 11, 1223-1229 (2004).
16. Forbes, S.A. et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945-D950 (2011).
17. Kendellen, M.F., Barrientos, K.S. & Counter, C.M. POT1 association with TRF2 regulates telomere length. Mol. Cell Biol. 29, 5611-5619 (2009).
18. Wu, L. et al. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126, 49-62 (2006).
19. Hockemeyer, D., Sfeir, A.J., Shay, J.W., Wright, W.E. & de Lange, T. POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J. 24, 2667-2678 (2005).
20. Hockemeyer, D., Daniels, J.P., Takai, H. & de Lange, T. Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 126, 63-77 (2006).
21. Martínez, P. & Blasco, M.A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer 11, 161-176 (2011).
22. Roos, G. et al. Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood 111, 2246-2252 (2008).
23. Lin, T.T. et al. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis. Blood 116, 1899-1907 (2010).
24. Stephens, P.J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011).
25. Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53-58 (2012).
26. Barrientos, K.S. et al. Distinct functions of POT1 at telomeres. Mol. Cell Biol. 28, 5251-5264 (2008).
27. Hudson, T.J. et al. International network of cancer genome projects. Nature 464, 993-998 (2010).
28. Larkin, M.A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948 (2007).
29. Waterhouse, A.M., Procter, J.B., Martin, D.M., Clamp, M. & Barton, G.J. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189-1191 (2009).
30. Baumann, P., Podell, E. & Cech, T.R. Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol. Cell Biol. 22, 8079-8087 (2002).
31. Blasco, M.A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34 (1997).
32. Samper, E. et al. Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase-deficient mice and primary cells despite increased chromosomal instability. J. Cell Biol. 154, 49-60 (2001).
33. Canela, A., Vera, E., Klatt, P. & Blasco, M.A. High-throughput telomere length quantification by FISH and its application to human population studies. Proc. Natl. Acad. Sci. USA 104, 5300-5305 (2007).